Subtopic Deep Dive

Fractional Flow Reserve
Research Guide

What is Fractional Flow Reserve?

Fractional Flow Reserve (FFR) measures the ratio of maximum blood flow distal to a coronary stenosis to the theoretically normal flow in the same vessel to assess hemodynamic significance during percutaneous coronary intervention.

FFR uses pressure wires to compute Pd/Pa under hyperemia, guiding decisions on revascularization for intermediate stenoses. FAME and FAME 2 trials demonstrated FFR-guided PCI reduces events compared to angiography alone (Pijls et al., 2010; 1117 citations; De Bruyne et al., 2012; 2666 citations). Guidelines endorse FFR for multivessel disease and stable CAD (Windecker et al., 2014; 4287 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

FFR improves patient selection by identifying ischemia-causing lesions, reducing unnecessary stenting and urgent revascularizations in stable CAD (De Bruyne et al., 2012). In multivessel disease, FFR guidance lowers mortality and MI at 2 years versus angiography (Pijls et al., 2010). ESC and ACC guidelines integrate FFR to optimize PCI outcomes and prognosis (Windecker et al., 2014; Levine et al., 2011).

Key Research Challenges

Hyperemia Induction Safety

Adenosine-induced hyperemia for FFR risks bronchospasm and AV block in some patients. Trials like FAME 2 noted adverse events in 1-2% of cases (De Bruyne et al., 2014). Non-hyperemic indices seek alternatives but lack long-term validation (Pijls et al., 2010).

FFR in Acute Syndromes

FFR accuracy drops post-MI due to microvascular dysfunction, limiting use in STEMI or NSTEMI. COMPLETE trial showed preventive PCI benefits without FFR, challenging its routine application (Wald et al., 2013). Guidelines recommend caution (Hamm et al., 2011).

Cost-Effectiveness Adoption

Pressure wire costs delay FFR uptake despite outcome benefits. FAME trial economics favor FFR long-term, but upfront expenses deter centers (Pijls et al., 2010). Guidelines urge implementation despite barriers (Windecker et al., 2014).

Essential Papers

1.

2014 ESC/EACTS Guidelines on myocardial revascularization

Stephan Windecker, Philippe Kolh, Fernándo Alfonso et al. · 2014 · European Heart Journal · 4.3K citations

peer reviewed

2.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Glenn N. Levine, Eric Bates, James C. Blankenship et al. · 2011 · Circulation · 3.3K citations

4.

Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease

Bernard De Bruyne, Nico H.J. Pijls, Bindu Kalesan et al. · 2012 · New England Journal of Medicine · 2.7K citations

In patients with stable coronary artery disease and functionally significant stenoses, FFR-guided PCI plus the best available medical therapy, as compared with the best available medical therapy al...

6.

Guidelines for Percutaneous Coronary Interventions

Sigmund Silber, Per Albertsson, Francisco Fernández‐Avilés et al. · 2005 · European Heart Journal · 1.6K citations

In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with on...

7.

Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease

Nico H.J. Pijls, William F. Fearon, Pim A.L. Tonino et al. · 2010 · Journal of the American College of Cardiology · 1.1K citations

Routine measurement of FFR in patients with multivessel CAD undergoing PCI with drug-eluting stents significantly reduces mortality and myocardial infarction at 2 years when compared with standard ...

Reading Guide

Foundational Papers

Start with FAME trial (Pijls et al., 2010) for core multivessel evidence, FAME 2 (De Bruyne et al., 2012) for stable CAD superiority, ESC guidelines (Windecker et al., 2014) for clinical integration.

Recent Advances

FAME 2 follow-up (De Bruyne et al., 2014; 1028 citations) confirms long-term benefits; COMPLETE (Wald et al., 2013) contrasts preventive PCI without FFR.

Core Methods

Hyperemia via adenosine/icor, Pd/Pa computation, cutoff 0.80; trials use drug-eluting stents with FFR >0.80 deferred (Pijls et al., 2010).

How PapersFlow Helps You Research Fractional Flow Reserve

Discover & Search

Research Agent uses searchPapers and citationGraph to map FFR trials from FAME (Pijls et al., 2010) hubs, revealing 4287-citation guideline impacts (Windecker et al., 2014); exaSearch uncovers meta-analyses, findSimilarPapers links FAME 2 (De Bruyne et al., 2012) to multivessel studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract FAME 2 event rates (De Bruyne et al., 2012), verifyResponse with CoVe checks claims against abstracts, runPythonAnalysis computes hazard ratios via pandas on trial data; GRADE grading scores FAME evidence as high-quality randomized trials.

Synthesize & Write

Synthesis Agent detects gaps like acute MI FFR limits from guideline contradictions (Windecker et al., 2014 vs. Hamm et al., 2011); Writing Agent uses latexEditText for methods sections, latexSyncCitations for 10+ FFR papers, latexCompile for reports, exportMermaid diagrams FFR vs. angio decision trees.

Use Cases

"Run meta-analysis on FFR-guided PCI event rates from FAME trials"

Research Agent → searchPapers('FFR FAME trials') → Analysis Agent → runPythonAnalysis(pandas forest plot on HRs from Pijls 2010, De Bruyne 2012) → researcher gets CSV of pooled risk reductions with p-values.

"Draft guideline-compliant FFR protocol in LaTeX"

Synthesis Agent → gap detection(FFR in multivessel) → Writing Agent → latexEditText(protocol) → latexSyncCitations(Windecker 2014, Levine 2011) → latexCompile → researcher gets PDF manuscript with synced refs.

"Find code for FFR pressure wire simulations"

Research Agent → paperExtractUrls(FFR modeling papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets validated GitHub repos with hemodynamic simulation scripts.

Automated Workflows

Deep Research workflow scans 50+ FFR papers via searchPapers → citationGraph(FAME cluster) → structured report with GRADE scores on guidelines (Windecker et al., 2014). DeepScan applies 7-step CoVe to verify FAME 2 outcomes (De Bruyne et al., 2012) against abstracts. Theorizer generates hypotheses on non-hyperemic FFR from Pijls et al. (2010) trial gaps.

Frequently Asked Questions

What is Fractional Flow Reserve?

FFR is Pd/Pa ratio ≤0.80 under hyperemia indicating ischemia, guiding PCI (Pijls et al., 2010).

What methods compute FFR?

Pressure wire measures distal/proximal pressure post-adenosine; iFR as non-hyperemic alternative emerging in trials (De Bruyne et al., 2012).

What are key FFR papers?

FAME (Pijls et al., 2010; 1117 citations), FAME 2 (De Bruyne et al., 2012; 2666 citations), ESC guidelines (Windecker et al., 2014; 4287 citations).

What are open problems in FFR?

FFR validation in ACS, hyperemia-free alternatives, cost barriers despite outcome gains (Hamm et al., 2011; Wald et al., 2013).

Research Coronary Interventions and Diagnostics with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Fractional Flow Reserve with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.